Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

OBJECTIVES: To evaluate the effectiveness of adalimumab in patients with psoriatic arthritis (PsA) and identify predictors of good clinical response for joint and skin lesions. METHODS: Patients received adalimumab 40 mg every other week in addition to standard therapy in this prospective, 12-week,...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Bosch, F, Manger, B, Goupille, P, McHugh, N, Rødevand, E, Holck, P, van Vollenhoven, R F, Leirisalo-Repo, M, FitzGerald, O, Kron, M, Frank, M, Kary, S, Kupper, H
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Clinical and epidemiological research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800202/
https://www.ncbi.nlm.nih.gov/pubmed/19815494
http://dx.doi.org/10.1136/ard.2009.111856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800202/
https://www.ncbi.nlm.nih.gov/pubmed/19815494
http://dx.doi.org/10.1136/ard.2009.111856

Ejemplares similares